Takeda Pharmaceutica
4502
End-of-day quote Tokyo - 10/19
4641JPY
-1.34%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Engages in the manufacture, sale, marketing, import and export of pharmaceutical products

Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs.

It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other.

The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products.

The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs.

The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products.

The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.

Number of employees : 27 230 people.
Sales per Businesses
20172018
JPY
(in Million)
%JPY
(in Million)
%
Prescription Drug1,568,87090.6%--
Consumer Healthcare82,5724.8%--
Other80,6074.7%--
Pharmaceutical--1,693,84095.7%
Intellectual Property Rights and Services--76,6934.3%
Sales per Regions
20172018
JPY
(in Million)
%JPY
(in Million)
%
Japan655,34437.8%580,34932.8%
United States520,16130%598,34133.8%
Europe and Canada279,69316.1%313,72317.7%
Asia112,7996.5%104,0265.9%
Latin America72,5164.2%75,6584.3%
Russia / Commonwealth of Independent States57,5503.3%68,2403.9%
Other33,9872%30,1941.7%
Managers
Name Title
Christophe Weber President, CEO & Representative Director
Costa Saroukos Chief Financial Officer
Andrew S. Plump Director, Chief Medical & Scientific Officer
Yasuhiko Yamanaka Managing Director & Head-Globalization
Masato Iwasaki Director & President-Japan Pharma Business Unit
Masahiro Sakane Independent Outside Director
Shiro Kuniya Independent Outside Director
Yoshiaki Fujimori Independent Outside Director
Emiko Higashi Independent Outside Director
Michel Orsinger Independent Outside Director
Shareholders
Name Equities %
Parametric Portfolio Associates LLC 1,729,785 0.11%
Glenmede Investment Management LP 368,960 0.023%
Pacer Advisors, Inc. 109,912 0.0069%
NorthCoast Asset Management LLC 98,803 0.0062%
FNY Capital Management LP 89,600 0.0056%
World Asset Management, Inc. 40,223 0.0025%
Kepos Capital LP 20,000 0.0013%
SEI Investments Management Corp. 18,545 0.0012%
Aperio Group LLC 18,144 0.0011%
Envestnet Asset Management, Inc. 14,534 0.0009%
Company contact information
1-1 Doshomachi 4-chome
JP-540-8645 Nishi-ku, Osaka
Japan

Phone : +81 6 6204 2111
Fax : +81 6 6204 2880
Internet : http://www.takeda.co.jp
Markets and indexes
- Tokyo Stock Exchange
- First Section
- Nikkei 225 / Stoxx Asia Pacific 50
Stock Exchange Codes
- ISIN Code :  JP3463000004
- Bloomberg Code :  4502:JP
- Reuters Code :  4502.T
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
TAKEDA PHARMACEUTICAL CO LTD-28.60%33 229
JOHNSON & JOHNSON-4.19%374 244
PFIZER20.87%257 933
NOVARTIS0.07%220 104
ROCHE HOLDING LTD.-4.56%206 610
MERCK AND COMPANY23.44%192 044
AMGEN12.47%131 215
ELI LILLY AND COMPANY30.81%121 694
SANOFI4.79%111 648
ASTRAZENECA9.72%97 642
GLAXOSMITHKLINE10.67%97 595
BRISTOL-MYERS SQUIBB COMPANY-6.15%91 352
BAYER-23.72%83 840
NOVO NORDISK A/S-18.37%83 253
ALLERGAN PLC12.04%64 118
CELGENE CORPORATION-21.59%58 344
SHIRE11.74%54 229
CHUGAI PHARMACEUTICAL CO LTD17.85%33 880
ASTELLAS PHARMA INC30.28%32 901
JIANGSU HENGRUI MEDICINE CO LTD8.53%29 434
DAIICHI SANKYO COMPANY, LIMITED51.29%28 424